We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$80.1B
AUM Growth
+$9.71B
Cap. Flow
+$17.3B
Cap. Flow %
21.56%
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$13B
2
NVDA icon
NVIDIA
NVDA
+$468M
3
ASML icon
ASML
ASML
+$424M
4
AMAT icon
Applied Materials
AMAT
+$310M
5
QCOM icon
Qualcomm
QCOM
+$307M

Top Sells

Rank Stock Value
1
KGC icon
Kinross Gold
KGC
+$444M
2
TYL icon
Tyler Technologies
TYL
+$256M
3
CHRW icon
C.H. Robinson
CHRW
+$251M
4
PM icon
Philip Morris
PM
+$245M
5
RTX icon
RTX Corp
RTX
+$234M

Sector Composition

Rank Sector Weight
1 Technology 40.76%
2 Materials 26.89%
3 Healthcare 7.04%
4 Industrials 6.5%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWR
1426
DELISTED
SunPower Corporation Common Stock
SPWR
-1,698
Closed -$5K
IAUF
1427
DELISTED
iShares Gold Strategy ETF
IAUF
-14,798
Closed -$905K
SLCA
1428
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-1,226,466
Closed -$18.9M
ETRN
1429
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-321,158
Closed -$4.17M
OSG
1430
DELISTED
Overseas Shipholding Group Inc.
OSG
-15,727
Closed -$133K

Similar funds

VanEck Associates's Q3 2024 Portfolio in Review

As of Q3 2024, VanEck Associates held 1,430 positions worth $80.1B, up 14% from $70.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VanEck Associates deployed $17.3B of net new capital in Q3 2024, opening 62 new positions and adding to 858 existing holdings. Its largest new stake was GE HealthCare: 2,335,235 shares worth $209M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Healthcare.

On the sell side, the largest reduction was Kinross Gold, an estimated $444M trimmed.

  • VanEck Associates's largest Q3 2024 buy was GE HealthCare: 2,335,235 shares worth $209M.
  • VanEck Associates added most to Lam Research in Q3 2024, an estimated $13B increase.
  • VanEck Associates's biggest Q3 2024 reduction was Kinross Gold, cutting an estimated $444M.
  • VanEck Associates fully exited RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock in Q3 2024, selling an estimated $22.4M.
  • VanEck Associates's ten largest holdings make up 29% of its $80.1B portfolio in Q3 2024.
  • VanEck Associates opened 62 new positions and closed 53 in Q3 2024.
  • VanEck Associates's portfolio value rose 14% quarter-over-quarter to $80.1B.

Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.